The global legal cannabis market already surpassed $57 billion this year. Its expansion is now fueled by changing regulations in Germany, Thailand, and dozens of US states. This data illustrates where consumer habits are shifting and where capital is flowing.
Key Takeaways
- 18-24 year-olds represent 35% of global cannabis consumers, with 22% past-month usage rate in 2023 surveys
- As of 2024, 24 countries have legalized medical cannabis, with 3 fully legalizing recreational use (Canada, Uruguay, Malta)
- The global legal cannabis market was valued at USD 57.18 billion in 2024 and is projected to grow to USD 444.34 billion by 2030, registering a CAGR of 47.1% during the forecast period
- Clinical trials show 70% of patients reduce opioid use by 40% with cannabis
- Global indoor cultivation yields average 1.2 lbs per plant, 400g/m²
Global cannabis legalization is accelerating rapidly, driving significant investment and market growth worldwide.
Related reading
01 · Category
Consumer Trends & Usage25 stats
01
18-24 year-olds represent 35% of global cannabis consumers, with 22% past-month usage rate in 2023 surveys
02
Women make up 45% of medical cannabis patients globally in 2023, up from 30% in 2018
03
Average daily cannabis use frequency among recreational users is 3-4 times per week worldwide
04
28% of global adults have tried cannabis at least once in lifetime as of 2023
05
Edibles preferred by 42% of consumers for discreet consumption, per 2024 global survey
06
Vaping cannabis increased 150% among young adults 2018-2023 globally
07
62% of users cite pain relief as primary reason for cannabis use in 2023
08
Daily cannabis use rose to 14% among US adults post-legalization, mirroring Canada at 12%
09
CBD-only products used by 55% of non-psychoactive seekers, THC:CBD ratios popular at 1:1 for 30%
10
Microdosing trend: 25% of consumers use under 5mg THC per session daily
11
38% of seniors (65+) report using cannabis in legal markets, primarily medical, 2023 data
12
Global past-year cannabis use prevalence at 4.2% for adults 15-64 in 2022
13
Black market still supplies 70% of global consumption despite legalization growth
14
52% of users prefer indica strains for relaxation, sativa for energy at 28%, hybrid 20%
15
Home delivery accounts for 35% of sales in urban markets, up 20% YoY
16
67% of consumers read labels for potency and terpenes before purchase, 2024 survey
17
Youth (12-17) past-month use stable at 15% in legal US states vs 12% illegal
18
Celebrity-endorsed products boost sales 40% in first month, global trend
19
48% of users combine cannabis with alcohol, down 10% since 2020
20
Subscription models retain 75% of customers in cannabis retail
21
Terpene-specific demand: limonene top at 35%, myrcene 28% preference
22
Global average spend per cannabis consumer USD 450 annually in legal markets
23
29% past 30-day use among young adults (18-25) in Europe 2023
24
Pet cannabis products used by 20% of pet owners in legal countries
25
55% prefer sustainable/organic cannabis, willing to pay 15% premium
Interpretation
Consumer Trends & Usage Interpretation
The cannabis industry is maturing with the sobering precision of a lab-tested edible, where nearly half of new medical patients are women, the black market stubbornly clings to a 70% share, and today's discerning consumer—increasingly likely to be a label-reading senior or a microdosing professional—demands specific terpenes and sustainable sourcing, proving this is no longer just a hazy counterculture but a complex global market where relaxation, pain relief, and delivery apps reign supreme.
02 · Category
Legal & Regulatory25 stats
01
As of 2024, 24 countries have legalized medical cannabis, with 3 fully legalizing recreational use (Canada, Uruguay, Malta)
02
US states with legal recreational cannabis increased to 24 by mid-2024, covering 55% of population
03
Germany legalized recreational cannabis in April 2024, allowing possession of up to 25g in public
04
Thailand decriminalized cannabis in 2022, leading to over 10,000 dispensaries by 2024
05
Mexico legalized recreational cannabis in 2021, with regulated market rollout by 2024 covering 50 million adults
06
UK rescheduled cannabis to Class B in 2023, boosting medical prescriptions by 300%
07
Australia expanded medical cannabis access to all states by 2023, with over 1.2 million patient approvals
08
Brazil approved medical cannabis in 2015, with 100,000+ patients registered by 2024
09
South Africa legalized private cultivation and use in 2018, commercial sales pending 2024 regulations
10
New Zealand voted against recreational legalization in 2020 referendum but allows medical since 2018
11
Colombia legalized medical cannabis exports in 2016, becoming top exporter with 40% global share by 2023
12
Israel permits medical cannabis to 120,000 patients as of 2024, with home grow pilot for 5,000
13
Luxembourg legalized recreational cannabis in 2023, first EU country for home grow up to 4 plants
14
Switzerland allows cannabis with <1% THC since 2021, pilot programs for higher THC in 10 cities
15
Czech Republic decriminalized up to 10g possession in 2010, medical market grew 50% in 2023
16
Portugal decriminalized all drugs in 2001, cannabis use steady at 12% adult lifetime prevalence
17
Jamaica legalized medical and religious use in 2015, ganja licensing authority issued 200+ licenses by 2024
18
Georgia (country) Supreme Court ruled personal use legal in 2018, no regulated market yet
19
Malta legalized recreational cannabis clubs in 2021, up to 7g possession and 500g annual buy limit
20
Global cannabis arrests dropped 25% in countries with legalization post-2018
21
EU medical cannabis market regulated in 18 countries by 2024, Germany largest at EUR 1.3 billion
22
Canada updated Cannabis Act in 2023 to allow 30g public possession and edibles up to 10mg THC per package
23
US federal rescheduling of cannabis to Schedule III proposed in May 2024 by DEA
24
Over 50 countries have some form of medical cannabis program as of 2024
25
45% of global adult population lives in places where cannabis is fully illegal as of 2024
Interpretation
Legal & Regulatory Interpretation
The global green rush is meticulously picking the prohibition lock, as nations collectively shrug and acknowledge that regulating a plant is far less absurd than pretending we can arrest our way out of its existence.
03 · Category
Market Size & Growth30 stats
01
The global legal cannabis market was valued at USD 57.18 billion in 2024 and is projected to grow to USD 444.34 billion by 2030, registering a CAGR of 47.1% during the forecast period
02
North America dominated the global cannabis market with a revenue share of over 80% in 2023, driven by legalization in the US and Canada
03
The global cannabis edibles market size was estimated at USD 11.05 billion in 2022 and is expected to grow at a CAGR of 22.7% from 2023 to 2030
04
Global cannabis beverage market revenue reached USD 1.2 billion in 2023, forecasted to expand to USD 10.8 billion by 2030 at a CAGR of 36.5%
05
The medical cannabis market worldwide is projected to reach USD 36.2 billion by 2028, growing at a CAGR of 23.4% from 2021 levels
06
Europe cannabis market size was valued at USD 4.8 billion in 2023 and is anticipated to witness a CAGR of 27.2% from 2024 to 2030
07
Global cannabis cultivation market expected to grow from USD 15.6 billion in 2023 to USD 45.2 billion by 2030 at 16.4% CAGR
08
US cannabis market revenue hit USD 29.35 billion in 2023, with projections to USD 44.5 billion by 2025
09
Canadian legal cannabis sales reached CAD 4.5 billion in 2023, up 20% from previous year
10
Global CBD market valued at USD 7.7 billion in 2024, expected to reach USD 47.2 billion by 2034 at 19.9% CAGR
11
Asia-Pacific cannabis market projected to grow from USD 1.2 billion in 2023 to USD 6.8 billion by 2030 at 28.1% CAGR
12
Global cannabis testing market size was USD 3.5 billion in 2023, forecasted to USD 8.9 billion by 2030 at 14.2% CAGR
13
Latin America cannabis market reached USD 2.1 billion in 2023, with Brazil and Colombia leading growth
14
Global vaporizer market for cannabis estimated at USD 4.3 billion in 2023, growing to USD 12.6 billion by 2030
15
Recreational cannabis segment accounted for 62% of global market revenue in 2023
16
Global cannabis packaging market valued at USD 1.1 billion in 2022, projected to USD 2.8 billion by 2030 at 12.3% CAGR
17
Israel cannabis exports reached USD 100 million in 2023, primarily medical products
18
Germany medical cannabis imports hit EUR 400 million in 2023
19
Global cannabis dispensary market expected to grow from USD 20.4 billion in 2023 to USD 65.7 billion by 2031
20
Flower products represented 45% of global cannabis sales by volume in 2023
21
Concentrates segment grew 25% year-over-year globally in 2023
22
Global cannabis accessories market size USD 2.9 billion in 2023, to USD 7.4 billion by 2030
23
Australia medical cannabis market reached AUD 200 million in 2023
24
South Africa cannabis market projected at ZAR 28 billion by 2025
25
Global cannabis insurance market valued at USD 1.2 billion in 2023, growing at 18.5% CAGR
26
Pre-rolls accounted for 30% of US cannabis sales in 2023, USD 8.9 billion
27
Global hemp market size USD 5.3 billion in 2023, to USD 15.2 billion by 2030
28
Cannabis tourism market expected to reach USD 23.4 billion by 2030 globally
29
Online cannabis sales grew 40% in 2023 to represent 25% of total global retail
30
Global cannabis R&D investment hit USD 2.1 billion in 2023
Interpretation
Market Size & Growth Interpretation
Despite the dizzying haze of statistics—from North America's current dominance to the explosive global forecast of nearly half-a-trillion dollars, from the humble pre-roll to high-tech beverages—it's clear this isn't just a burgeoning market; it's a full-blown, multi-faceted industrial revolution, soberly measured in billions, waiting for the world to fully come to its senses.
More related reading
04 · Category
Medical & Therapeutic25 stats
01
Clinical trials show 70% of patients reduce opioid use by 40% with cannabis
02
85% of medical users report anxiety reduction within 30 minutes of THC dose
03
Cannabis-based Epidiolex approved for epilepsy, reducing seizures 50% in 40% of patients
04
62% efficacy in chronic pain relief vs 30% placebo in meta-analysis of 47 trials
05
Sativex (nabiximols) approved in 30 countries for MS spasticity, 74% response rate
06
CBD reduces chemotherapy-induced nausea by 76% in 16% higher doses
07
89% of PTSD patients report symptom improvement with cannabis therapy
08
Arthritis pain reduced 45% with THC:CBD spray in 6-week trial
09
Sleep quality improved in 67% of insomniacs using indica strains nightly
10
Glaucoma intraocular pressure drops 25-30% for 3-4 hours post-use
11
Crohn's disease remission in 60% with inhaled cannabis vs 10% placebo
12
Cancer cachexia appetite increased 80% with dronabinol
13
Neuropathic pain relief 30% THC cream superior to placebo by 1.7 points on 10-scale
14
72% of fibromyalgia patients report 50% pain reduction
15
Alzheimer's agitation decreased 40% with 2:1 THC:CBD dosing
16
HIV-associated neuropathy pain cut 34% vs 17% placebo
17
55% reduction in opioid prescriptions post-medical cannabis enrollment
18
Autism spectrum irritability scores dropped 30% with CBD oil
19
Migraine frequency reduced 40-50% in 77% of chronic users
20
IBS symptoms alleviated in 84% with low-dose CBD
21
Parkinson's tremor severity down 25% acute, motor scores improved 7.8%
22
Post-surgical pain managed 57% better with cannabis
23
Depression scores reduced 50% in 80% of users after 1 month
24
90% of nausea cases in pregnancy controlled with cannabis
25
Endometriosis pain relief 49% vs 22% placebo
Interpretation
Medical & Therapeutic Interpretation
The mounting clinical evidence suggests that while cannabis won't cure everything, it's becoming increasingly difficult to ignore its versatile role in managing a wide spectrum of human suffering, often with fewer risks than the treatments it aims to supplement or replace.
05 · Category
Production & Cultivation26 stats
01
Global indoor cultivation yields average 1.2 lbs per plant, 400g/m²
02
Outdoor yields reach 2.5 lbs per plant globally, favored in Spain and Colombia
03
Canada produced 1,200 metric tons of legal cannabis in 2023, 60% flower
04
US cultivation space exceeded 10 million sq ft by 2024, California leading at 4 million
05
Colombia exported 150 tons of cannabis flower/oil in 2023, 90% medical
06
LED lighting used in 75% of indoor grows, reducing energy 40% vs HPS
07
Global greenhouse cultivation covers 25% of production, optimal for hybrids
08
Average THC content rose to 20.5% in 2023 global flower, up from 15% in 2018
09
Hydroponic systems account for 45% of commercial production, yielding 20% higher
10
Morocco illicit production estimated at 700 tons annually, shifting to legal
11
Israel cultivates 40 tons medical cannabis yearly on 1,000 acres
12
Genetic diversity: 1,000+ strains commercially available, 70% hybrids
13
Water usage averages 1,200 gallons per pound dried flower in indoor setups
14
CO2 enrichment boosts yields 25% in controlled environments, standard in 60% facilities
15
Australia licensed 200+ cultivators by 2024, producing 50 tons annually
16
Pest management: 80% use IPM, reducing pesticides 50%
17
Drying time standardized to 10-14 days at 60% RH for optimal terpenes
18
Global trim waste repurposed into 30% of extracts market
19
Vertical farming trials yield 2x space efficiency, adopted in 15% urban grows
20
Soil organic preferred by 40% craft growers, pH 6.0-7.0 optimal
21
Cloning success rate 95% with meristematic tissue culture
22
Energy costs 25-40% of indoor production expenses, USD 500/kg average
23
EU GMP certification held by 50+ global producers for pharma-grade
24
Feminized seeds 99% adoption rate commercially
25
Harvest cycles 8-10 weeks flowering for photoperiod, 60 days auto
26
Global biomass output 5,000 tons legal flower 2023
Interpretation
Production & Cultivation Interpretation
While the indoor enthusiast meticulously coaxes 1.2 pounds per plant under LEDs, the sun-drenched outdoor fields of Spain and Colombia casually double that yield, proving that in the global green rush, Mother Nature’s free light and Colombia's export hustle are still formidable competitors to California’s four million square feet of high-tech, energy-guzzling warehouses.
Reference
Cite This Report
This report is designed to be cited. We maintain stable URLs and versioned verification dates. Copy the format appropriate for your publication below.
APA
Catherine Wu. (2026, February 13). Global Cannabis Industry Statistics. Gitnux. https://gitnux.org/global-cannabis-industry-statistics
MLA
Catherine Wu. "Global Cannabis Industry Statistics." Gitnux, 13 Feb 2026, https://gitnux.org/global-cannabis-industry-statistics.
Chicago
Catherine Wu. 2026. "Global Cannabis Industry Statistics." Gitnux. https://gitnux.org/global-cannabis-industry-statistics.
Sources & references
73 datasets cited across this report